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1. Introduction 
Nuclear medicine practices rely on the use of radiopharmaceuticals, for diagnosis and 
therapy purposes. Their use is based on the incorporation in the human body through a 
medical procedure: intravenous injection, ingestion, or inhalation. The quality of the 
administration procedure is tightly influenced by the following determining factors: the 
administration of the right activity to the patient, such as prescribed by the medical doctor, 
and the quality of the radiopharmaceutical product. The full control of these parameters is 
obtained by using high quality measurement equipment and following well established 
procedures for the measurement and application of the radiopharmaceutical. 
The radiopharmacy units, the measurement equipment providers and the nuclear medicine 
units can fulfill these requirements only by using calibrated instrumentation and following 
validated measurement methods. The technical support is offered by the Radionuclide 
Metrology Laboratories (RML) which can assure the continuity of the metrological 
traceability chain of measurement up to the highest, primary radioactivity standards. The 
metrological traceability and its chain are defined by the document: “BIPM, JCGM 200:2008 
– International vocabulary of metrology – Basic and general concepts and associated terms (VIM)”, 
as:  
- “Metrological traceability – property of a measurement result whereby the result can be related 
to a reference through a documented unbroken chain of calibrations, each contributing to the 
measurement uncertainty” 
- “Metrological traceability chain – sequence of measurement standards and calibrations that is 
used to relate a measurement result to a reference” 
From these definitions one can deduce the role of the RMLs: to develop activity standards, 
to validate them in relation with the International System of Units (SI) and to disseminate 
them as radioactive standard sources and solutions, or calibration services to the implied 
entities. 
This chapter of the book presents the following aspects: 
- Measurement requirements in radiopharmacy, in measurement instrument calibration 
process, and in nuclear medicine units; 
- Role of the Radionuclide Metrology Laboratory in the practical accomplishment of 
these requirements  
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2. Radiopharmaceutical products and their characterization by 
measurements 
2.1 Types of radiopharmaceutical products 
A radipharmaceutical (RPM) product contains a radionuclide in an adequate chemical form, 
the transporter, which conducts it towards the organ or tissue of interest, when it is 
administrated to the patient “in vivo” by ingestion, inhalation or intravenous injection. In the 
case of diagnosis the radionuclide is used as a “tracer”, while in therapy it is employed due to 
the cytotoxic effect of the emitted ionizing radiations. The radiopharmaceuticals are presented 
as ingerable gelatin capsules (or solutions), injectable solutions and inhalation gases. 
2.1.1 Transporters 
Various types of transporters are used, formulated such as to assure a maximum localization 
of the radiopharmaceutical in the zone of interest while exposing the neibouring area to 
minimum detriment (Kornyei.2008, Mikolajczak. 2008). The types of transporters are 
generally similar for both of nuclear medicine procedures, diagnosis and therapy; some 
formulations are presented as follows: 
- Simple inorganic compounds such as salts, containing the radionuclide in an ionic form: 
Na99mTcO4, 131INa, 89SrCl2, Na186,188ReO4  
- Simple gas molecules: 11CO2, 15O2, 81mKr 
- Labeled organic molecules: 18F-DG; 67Ga-cytrate 
- Metal-ligand complexes: 99mTc-MDP, DTPA; 188Re-HEDP; 177Lu-EDTMP  
- Colloids, labeled micro and nano spheres: 99mTc-fytate  
- Labeled biomolecules: 
i. Monoclonal antibodies (mAb): 90Y-anti-CD20; 188Re-anti-VEGF  
ii. Meta Iodo Benzil Guanidine (MIBG)-131I 
iii. Peptide Receptor Radionuclide, somatostatin analogous: Pentetroid-DTPA-111In, 
TOC-HYNIC-99mTc. 188Re-DOTA-Lan and 188Re-Lan. 
The detailed description of these compounds is outside the scope of the chapter. 
2.1.2 Radionuclides 
In contrast with the transport molecules, the choice of the radionuclides differs for the two 
types of nuclear medicine procedures: diagnosis and therapy. 
Radionuclide diagnosis principle: The incorporated radiopharmaceutical product, localized 
at the interest zone emits gamma-rays, which cross the body and are detected by the gamma 
cameras, containing a detection system, based on the use of scintillation detectors and a 
network of photomultipliers. A bi-dimensional image, called scintigram, is obtained; if the 
computer tomography principle is applied, a 3D image appears. In principle it is necessary to 
use as much as possible of the emitted radiation for detection and to avoid the unnecessary 
irradiation of the body; the irradiation detriment is expressed in terms of committed effective 
dose per activity unit, E/A. For this reason, the choice of radionuclides is focussed on the use of 
radionuclides with short half life and emitting low energy and intensity electrons and 
abundant gamma-rays, not much absorbed inside the body, and situated in the optimal energy 
detection interval, 100 – 600 keV. Two types of diagnosis procedures are in use: 
- Single Photon Emission Tomography (SPET) is based on the use of a single detector and 
of radionuclides decaying by isomeric transition, such as 99mTc, and by electron capture, 
123I. As an exception, 131I emitting beta-gamma radiations, is still used in some special 
procedures, like the iodine uptake in thyroidal investigations. 
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- Positron Emission Tomography (PET), sometimes associated with x-ray tomography, 
PET/CT. In this case, radionuclides decaying by positron emission are used. The 
stopped, or in flight, positron annihilates with a neighbouring electron, and two 511 
keV annihilation quanta at an angle of 1800 are emitted. These quanta can be detected in 
coincidence, using two detectors situated at 1800. The procedure allows a much better 
resolution and consequently a more precise diagnosis, due to the measurement of 
coincident radiations. The positron emitters used for PET systems have short half life 
and for this reason the E/A value is low, although they emit positive electrons, absorbed 
inside the body. The most used radionuclide is 18F.  
Table 1 presents a list of radionuclides used for the production of radiopharmaceuticals, in 
terms of production mode, nuclear decay data and E/A. Referring the E/A value, it is 
strongly dependent on the type of radiopharmaceutical, diagnostic procedure and the age of 
the patient; only for a rough information, the comparative dose values due to the ingestion 
of radionuclides by the adult public (ICRP 1996c) are given, in order to emphasize the 
strong dependence of the dose on the characteristics of the nuclear decay scheme. 
The values of E/A from Table 1 are based on the Medical Internal Radiation Dose (MIRD) 
model, while at present time the calculation models use the “voxel phantom”, defined in 
international documents as ”a computational anthropomorphic phantom based on medical 
tomographic images where the anatomy is described by small three dimensional volume elements 
(voxels) specifying the density and the atomic composition of the various organs and tissues of the 
human body”. A special attention is paid to the radionuclide 99mTc, used nowadays in about 
80% of the world diagnosis procedures. Its widespread use is due to several properties:  
i. Its committed effective dose of activity unit is E/A =0.022mSv/MBq and the 
corresponding doses in the diagnostic procedures are generally within the limits (1 -2) 
mSv, due to the short half-life and to the small content of low energy electrons.  
ii. The 140.5 keV quanta are emitted with a high intensity, being situated near the 
maximum detection efficiency of the usual scintillators.  
iii. It can be extracted from a 99Mo generator (2.75 d,) a reasonable life time for transport 
and use for a period of two weeks, or can be prepared in a pharmaceutical unit and 
delivered to the neighboring hospitals in the same day.  
iv. It is carrier free and due to its position in the Mendeleev Table, the VII-b group, with 7 
valence electrons, it can be used for binding in various chemical compounds, with 
various valence states. 
Radionuclide (targeted) therapy principle. The incorporated radiopharmaceutical is 
localized in the biological formation to be destroyed by irradiation. In this case, the entire 
energy of particles must be transferred to the matter. Consequently, low range radiations, 
such as: alpha particles and electrons - beta radiation, Auger and conversion electrons, are 
useful. This is the reason for which alpha, strong beta with high energy, electron capture 
and conversion decaying radionuclides are used. Lately a special attention is given to the 
beta-gamma triangular decay scheme radionuclides, with strong beta and weak gamma – 
ray energies and intensities, due to the ability to be monitored by a gamma camera during 
the treatment procedure. The half life can be from hours up to tens of days, in order to 
assure the prescribed dose to the biological formation to be destroyed. The choice of the 
radionuclides takes into account their chemical properties, as well as their radiations range 
in the tissue, which must be comparable with the dimensions of the biological formation to 
be destroyed. Table 2 presents a list of therapeutical radionuclides, with their modes of 
production, nuclear decay parameters and the tissue range.  
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Type of  
Diagnostic 
Radio 
nuclide
Obtaining Half life Emitted radiations E/A, 
mSv/MBq 
adults, 
ingestion  
Type Energy, keV Intensity 
% 
SPET 131I NR*:  
130Te (n,Ǆ)131Te, ǃ decay, 
131I, or 235U fission 
8.02 d ǃ_ 
Ǆ 
248-606 max
364.5 
100 
81.6 
22 
 123I Cyclotrone: 
123Te(p,n)123I 
13.2 h e 
X 
Ǆ 
127-158 
27-32 
159 
3.36 
85.6 
83.3 
0.22 
 67Ga Cyclotrone: 
67Zn(p,n)67Ga 
3.26 d e 
Ǆ 
84-93 
91 -393 
35 
87 
0.19 
 201Tl Cyclotrone: 
203Ta(d,4n)201Pb. E.C.201Tl
3.04 d e 
X 
Y 
16-153 
12-82 
167.5 
51.8 
140 
10 
0.095 
 99mTc NR: 
99Mo generator (2.75 d) 
98Mo(n, Ǆ)99Mo  
or 235U fission  
6.007 h e 
X 
Ǆ 
120-138 
18.3-20.7 
140.5 
11 
7.6 
89 
0.022 / 
diagnostic 
0.005-0.029 
(Toohey & 
Stabin. 1996) 
 111In Cyclotrone: 
111Cd(p,n)111In 
2.80 d e 
X 
Ǆ 
145-219 
23-27 
171.3 
245.4 
13.6 
3.2 
90.6 
94 
0.29 
81mKr Cyclotrone: 
 81Rb generator (4.25 h) 
79Br(ǂ,2n)81Rb 
12.8 s e 
X 
Ǆ 
176 -188 
12.6-14.1 
190.3  
32.1 
16.8 
67.1 
0.00004 
inhallation 
PET 18F Cyclotrone: 
18O(p,n)18F; 16O(ǂ,pn)18F; 
20Ne(d,ǂ)18F 
110 min ǃ+ 
 
Ǆ± 
634 max, 
tissue range 
2mm 
511 
96.9 
 
194 
0.049 
 11C Cyclotrone: 
14N(p, ǂ)11C 
20.4 min ǃ+ 
Ǆ± 
960 max 
511 
100 
200 
0.024 
 68Ga 68Ge generator (270.83 d)
Cyclotrone: 
66Zn(ǂ,2n)68Ge 
67.7 min ǃ+ 
Ǆ± 
1899 max 
511 
88 
178 
0.10 
 64Cu NR:63Cu(n,Ǆ)64Cu 
Cyclotrone: 
64Zn(d,2p)64Cu 
12.70 h ǃ± 
Ǆ± 
653 max 
511 
56.9 
35.7 
0.12 
 
NR* = Nuclear Reactor. In the future, most of NR produced radionuclides is expected to be obtained 
from high neutron flux sources, based on the use of a proton accelerator and the emission of neutrons 
by the accelerated protons reaction with a mercury target. 99Mo can be produced also at a linear 
accelerator: 
100 99
Mo( , ) Moγ n  
 
Table 1. The most used radionuclides for diagnosis. Monographie BIPM-5 (Bé et al. 2004), 
ICRP1996c (1996). 
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Type 
 
Radio 
nuclide 
Obtaining Half life Type of 
radiations 
Energy, keV; 
Intensity 
Tissue range  
Max./Mean 
Alpha 
emitters 
211At Cyclotrone  
209Bi (ǂ,2n)211At 
7.21 h ǂ 5868-7448; 
100% 
80 Ǎm 
 213Bi 
225Ac  
(10 d) 
generator  
225Ac is in 237Np 
decay chain 
or cyclotrone: 
226Ra(p,2n)225Ac 
45.6 min ǂ 
 
ǃ 
5869; 2% 
 
987-1426; 97% 
70 Ǎm 
 
2.5 mm 
 212Bi 
212Pb 
(10.64h) 
generator 
212Pb is in natural 
232Th chain,  
or Cyclotrone: 
210Po (t, p)212Bi 
Bi-212 
60.54 
min 
ǂ 
 
ǃ 
6050-6090 ; 
35.8% 
1527-2250 ; 
64.2% 
80 Ǎm  
 
4.0 mm 
Electron 
capture 
(EC) 
radio 
nuclides  
125I NR: 
124Xe (n, Ǆ) 125Xe, EC, 
125I 
59.90 d Auger L 
 
Auger K 
3.7; 79.3% 
 
22.7 - 34.5;  
33.9% 
Tens of nm 
 
about 47Ǎm 
117mSn NR: 
116Sn(n, Ǆ)117mSn 
13.6d Internal 
conversion 
electrons 
127 keV 
152 keV 
210 Ǎm 
290 Ǎm 
Pure beta 
emitters 
 
32P NR: 
32S(n,p)32P 
14.28 d ǃ Max 1710,  
mean 695.5; 
100% 
9.8 mm/ 
2.8 mm 
 90Y NR: 
89Y(n,Ǆ)90Y;  
 or 235U fission: 
Generator:  
90Sr (28.15 y): 
2.67 d ǃ Max 2284, 
mean 939; 100% 
12 mm/ 
 4.0 mm 
 
 
89Sr NR:  
88Sr (n,Ǆ)89Sr or  
235U fission 
50.65 d ǃ Max 1492,  
mean 584; 100% 
8 mm/ 
2.5 mm 
Beta -
gamma 
emitters 
131I NR: 
130Te(n, Ǆ)131Te, ǃ 
decay, 131I  
or 235U fission  
8.023 d ǃ Max 
338-605, 
mean  
97-192 ; 100% 
4mm/ 
0.8 mm 
 153Sm NR:  
152Sm(n, Ǆ) 153Sm 
1.956 d ǃ Max  
634-807 , 
mean 
200-263 ;100% 
5 mm/ 
1.2 mm 
 177Lu NR: 
176Lu (n, Ǆ)177Lu 
or: 
176Yb(n, Ǆ)177Yb,  
ǃ decay, 177Lu 
6.734 d ǃ Max  
175.8-497.1, 
mean  
47-149 ;100% 
1.6 mm/ 
0.7 mm 
 186Re** NR: 
185Re(n, Ǆ)186Re 
3.775 d ǃ Max  
939.4-1077,  
mean 
309-362; 93.1% 
5.0mm/ 
1.7 mm 
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Type 
 
Radio 
nuclide 
Obtaining Half life Type of 
radiations 
Energy, keV; 
Intensity 
Tissue range  
Max./Mean 
 188Re** NR: 
187Re(n, Ǆ)188Re  
or  
186W(n, Ǆ)187 W 
(n, Ǆ)188W (69.4 d) 
Generator  
16.98 h 
 
 
ǃ Max  
1962-2118. 
mean 
706-784;100% 
11 mm/ 
3.5 mm 
**) When a natural Rhenium target is irradiated, a mixture 186Re+188Re is obtained. It can be used in this 
composition, for the short time irradiation of the external part of large dimension tumors by 188Re and 
for the long time irradiation of their cores by 186Re. Otherwise, after a week period 188Re decays and 
almost pure 186Re is obtained. 186Re and 188Re are very important for the obtaining of therapy 
pharmaceuticals, due to their similar chemical behavior (VII b group) with 99mTc, very extensively 
studied. 
Table 2. Radionuclides used for therapy radiopharmaceuticals. 
2.2 Technical parameters of radiopharmaceuticals and control methods  
One radiopharmaceutical product is characterized by several types of parameters, whose 
determination requires a very good knowledge of the physico-nuclear parameters of the 
radionuclide and the use of adequate methods and equipment for measurements. Their 
accepted limit values and methods of determination are described in international and 
national technical regulatory documents, such as the European Pharmacopoeia (2002). It is 
considered that the radiopharmaceuticals are products with a high pharmaceutical risk. The 
parameters are determined first of all in the radiopharmacy, which must dispose of control 
laboratories in full compliance with the requirements for Good Laboratory Practice (GLP) 
and accredited according to the international standard “General Requirements for the 
Competence of Testing and Calibration Laboratories”, ISO/IEC 17025:2005. Their determined 
values are confirmed by the national control laboratories, or are internationally recognized 
by conventions. Some parameters are controlled only in radiopharmacy, while others are 
compulsory for the nuclear medicine units, mainly when supplementary operations are 
carried. A detailed description of the requirements and of their accomplishment mode, 
regarding quality assurance in radiopharmaceutical measurement is presented in the 
document Technical Report Series 454 (TRS 454), elaborated by the International Atomic 
Energy Agency (IAEA) (2006). 
Three types of radiopharmaceuticals’ parameters are generally defined and controlled: 
radiometrologic, physico-chemical and biological-microbiological parameters. 
2.2.1 Radiometrologic parameters and their determination 
(i) Activity, Bq, and derived quantity Radioactive Concentration (Massic Activity), expressed 
in Bq g-1 of solution, or Bq mL-1. These are basic parameters of a radiopharmaceutical 
product, as the precise determination of the activity administrated to the patient, in full 
compliance with the prescriptions of the medical doctor, determines his/her committed 
effective dose, mSv, in radionuclide diagnosis and absorbed dose in the organ/tissue, mGy, 
in radionuclide therapy, and assures the safety and effectiveness of the medical procedure. 
Due to this reason, the special requirements regarding the reporting of total activity of a 
radiopharmaceutical product, on a reference time, are specified by the Basic Safety Standards  
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(1996), para.II.19, such as follows: ”the calibration of sources used for medical exposure shall be 
traceable to a Standard dosimetry laboratory“ and “unsealed sources for nuclear medicine procedures 
shall be calibrated in terms of activity of the radiopharmaceutical to be administrated, the activity 
being determined and recorded at the time of administration”. The conclusion of these assertions 
is that the activity must be precisely measured and the metrological traceability up to the 
primary level must be assured. 
In radiopharmacy and nuclear medicine units, the activity is usually determined using 
Radionuclide Activity Calibrators, or Dose Calibrators. They contain a reentrant (well type) 
ionization chamber under pressure, connected to an electrometric system. The 
manufacturers perform the calibration of the equipment in terms of calibration factors, 
introduced in dial settings, established for a list of the most used medical radionuclides. The 
calibrations are performed using sets of standard solutions, provided by the radionuclide 
metrology laboratories or by commercial producers, having metrological traceability to a 
primary activity standard declared. Usually, these factors are determined for various types 
of recipients used in hospitals, such as: P6 or Schott 10-R vials, syringes, gelatin iodide 
capsules, etc. 
The pharmacopoeias impose the uncertainty limits in the measurement of activity, as: <5% 
for therapy and <10% for dignosis. The activity is measured in radiopharmacy, but it must 
be measured also in the hospital, as several operations, such as portioning, administration 
with a syringe, are carried by the involved staff. Due to the crucial importance of these 
measuremens, the radionuclide calibrator precision in the calibration and maintenance of its 
corresponding technical condition, together with the correct method of activity 
measurement in the nuclear medicine units are matters of concern at international level. The 
IAEA initiated a program aimed to improve and harmonize the quality of activity 
measurements. In November 2002 a group of consultants had a meeting in the IAEA Vienna 
headquarters, giving advice on the Methodology of Radioactivity Standardization. The 
Coordinated Research Project (CRP) codified as: E2.10.05, entitled: ”Harmonization of quality 
practices for nuclear medicine radioactivity measurements” was started in 2004. Following the 
recommendations of the first meeting, a second consultants meeting was held and 
recommended to develop a set of procedures in the form of a draft Code of Practice in 
radioactivity measurement. Among other results of the CRP deployment, the elaboration of 
the above named document TRS454: Quality Assurance for Radioactivity Measurement in 
Nuclear Medicine was very important. The document presents in detail (Table 4, page 69) the 
types of tests and acceptance criteria for radionuclide activity calibrators to be performed 
upon the initial acceptance in the unit or after repair, daily checks in the hospital, monthly 
and annually. As for accuracy of measurement, an upper limit of 5% is imposed. In this 
respect, a radionuclide metrology laboratory is the entity providing assurance of 
metrological traceability chain directly, by providing standards, by performing calibrations 
and by organizing proficiency tests among the personnel doing measurements in 
radiopharmacy, in the control authorities, at the calibrators’ producers and the nuclear 
medicine staff.The requirement of accuracy in the metrology laboratory is 2%. It can be 
primary activity standard, or a secondary one, metrologically traceable to a primary activity 
standard, disposing of a calibrated reentrant ionisation chamber, such as described by 
(Schrader, 1997).  
(ii) Specific activity, expressed in units, Bq g-1 of solid mass. It defines the activity of the 
mass unit of the chemical element or solid compound and determines the capacity of 
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labeling, mainly for biomolecules, and also the radiopharmaceutical’s toxicity for human 
body. Two situations must be taken into consideration: 
- Obtaining of the radionuclide. If the radionuclide is obtained in the nuclear reactor by 
neutron activation, generally it contains a mass of inactive carrier, which is determined 
by spectrophotometry, or by calculation from irradiation data. The accuracy of these 
calculations rely on the precision of irradiation data: neutron flux Φ, activation section 
σ, irradiation time t, but also on the target data such as mass M, isotopic composition η, 
radionuclide half life, T1/2. In the case of radionuclides obtained by irradiation at 
cyclotrone, or separated from a radionuclide generator, or when the radionuclide of 
interrest is different from the irradiated target, as for example 131I obtained by 
irradiation of 130Te, the obtained radionuclide is carrier free. 
- Obtaining of the radiopharmaceutical product. In this case, the specific activity depends 
on the labeling yield, such as the labeling of various kits with 99mTc in the hospital, 
under the use of stanous chloride as catalist. 
2.2.2 Physico-chemical parameters  
(i) Radionuclidic purity, expressed as the ratio between the activity of the base 
radionuclide and total activity. This parameter is important from two points of view:  
i. influence of impurities on accuracy of activity measurements and  
ii. their contribution in the committed effective dose of the patient, mainly when the 
impurities have values of the E/A higher than the main radionuclide. One relevant 
example is the (99Mo- 99mTc) generator, where (E/A)Mo-99 =1.2 mSv/MBq, 55 times higher 
than for 99mTc; a 2% 99Mo impurity will duplicate the committed effective dose. For this 
reason the 99Mo impurity in 99mTc elute, known as “molybdenum breakthrough”, is 
restricted at 0.1%. The precise determination of impurity level depends on the 
knowledge of the decay parameters, such as presented in the Monographie BIPM-5 
(2004): half life, type and intensity of emitted radiations for all impurities and also on 
the precision of the method used in determination. In the simple case, when the 
involved radionuclides are gamma-ray emitters, the well-known gamma-ray 
spectrometry method, based on spectrometers provided with high resolution HPGe or 
Ge(Li) detectors, multichannel analyzers (MCA) and sets of software for processing of 
data, is used (Debertin & Helmer.1988). The energetic resolution is expressed in terms 
of full width at half maximum (FWHM) and reflects the ability of the system to 
distinguish two close energy full absorption peaks. Their calibration contains two 
components:  
- The energy calibration is expressed in terms of number of energy units per MCA 
channel (generally keV/channel) allowing the identification of all radionuclides 
contained in a sample;  
- The full absorption peak efficiency calibration consists in the determination of a 
calibration curve, generally expressed in terms of efficiency versus the logarithm of 
energy, used for the measurement of individual activities; it is established for a 
determined measurement geometry (distance detector – source) and for each type of 
measured recipient. The calibrations are performed by using sets of monoenergetic 
standard sources, covering the whole 50 keV – 3000 keV energy interval. The sets of 
standard sources are provided by a RML and are certified with uncertainties of (1- 5) 
%. The spectrometry systems are also provided with dedicated software sets, 
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allowing the determination of full absorption peak areas and for performing 
corrections for: geometry, matrix and sample volume, coincidence summation for 
multigamma emitting radionuclides. The determination of purity consists from the 
following steps: identification of the main radionuclide and of the impurities in the 
sample, according to the energy calibration; measurement of the areas of all full 
absorption peaks; calculation of individual activities, using the efficiency calibration 
curve and the gamma-ray emission intensity from the radionuclide decay scheme; 
calculation of the ratios between the activity of the main radionuclide and the sum 
(main radionuclide plus radio impurities). Generally, the impurity level is controlled 
only in the radiopharmacy, but in the case of molybdenum breakthrough, it must be 
controlled also in the hospital, due to the possible deterioration of molybdenum 
retention in the alumina column along its use. On this purpose, the radionuclide 
calibrators are usually provided with a lead shield, which absorbs the 99m Tc, 140.5 
keV gamma-rays. The detection of sole 99Mo gamma-rays and use of 99Mo calibration 
factor, corrected for the absorption of its gamma-radiations in the shield, allows the 
determination of the impurity level, expressed as the ratio between 99Mo and 99mTc 
activities. The problem is more complex when pure beta or alpha-ray emitters are 
used. Some relevant examples: 
a. Determination of 90Sr content in 90Y when a 90(Sr+Y) generator is used. In this case, 
only liquid scintillation spectrometry (Grau Malonda et al. 1994) or counting is 
used (Wyngaardt. 2006).  
b. Determination of alpha and beta impurities in 99mTc, due to fission 99Mo used for 
generator production. In this case, the restrictive limits for alpha impurities are of 
the order of 10-9 and for beta emitters of the order of 10-6. This level of impurities is 
possible to be measured only after the complete decay of the 99m Tc elute by using 
the liquid scintillation counting, alpha/beta discrimination (Terlikowska et al. 
2000). 
(ii) Radiochemical purity or ratio between the activity of the main compound and sum of 
all chemical compounds. The determination is compulsory in the radiopharmacy, but it is 
advisable also in the hospital, when operations like the preparation of labeled kits is 
performed. For example, the determination of radiochemical purity of Labeled 99mTcMDP, 
expressed as the ratio: 99mTcMDP/( 99mTcMDP+Na99mTO4). This purity determination is 
important, as the tropism of the compound to the target organ/tissue is affected, resulting in 
the dangerous irradiation of other organs. The imposed limits are generally of 97-98%. The 
radiochemical purity is determined by using the radiochromatographic methods: either thin 
layer chromatography (TLC) or more sophisticated - high purity liquid chromatography 
(high pressure liquid chromatography)-HPLC. The determination consists of the measuring 
the activities of the two fractions and calculating the ratio between the activity of the main 
fraction and the sum of main and impurity fractions. The precision of measurement depends 
mainly on the linearity of the measurement instrument, which must be verified by using 
two standard sources with activity ratio of about 100, similar with the ratio of measured 
activities. The counting rates ratio must be equal with the ratio of sources activities, which 
must be certified with uncertainties <5%. 
(iii) Chemical purity, defined by the existence of some nonradioactive elements. The 
chemical impurities can be: alumina, cooper, ions types (NH4)+ or (NO3)- in 99mTc elutes 
from a generator. Their presence can produce the toxicity of the radiopharmaceutical, or can 
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deteriorate the labeling yield of the kits. They are usually determined in the radiopharmacy, 
but in some cases, the medicine units can dispose of the necessary equipment for control. 
The methods are specific to the analytical non radiation chemistry, such as 
spectrophotometry or colorimetry. 
2.2.3 Biological and microbiological parameters 
These parameters are of maximum importance mainly when the radiopharmaceutical is 
administrated as an injection, but they are beyond the scope of this chapter and will not be 
further presented. 
3. Primary standard radionuclide metrology laboratory  
From the content of section 2, one can conclude that the nuclear medicine applications of 
radionuclides raise many challenges to the nuclear physicists, from several points of view: 
- A very long list of radionuclides is used for the production of radiopharmaceuticals. 
Other new radionuclides, presenting convenient physico-nuclear and chemical 
properties, are discovered and introduced in the radiopharmaceutical use. 
- The quality requirements can only be accomplished by the very precise determination 
of the activity of radiopharmaceuticals and by a very deep knowledge of their physico-
nuclear characteristics, generally defined as the decay scheme parameters. These two 
aspects are interconnected, each one depending strongly on the other. 
The adequate solutions of these tasks are offered by the Radionuclide Metrology Laboratories, 
generally responsible national entities, which assure the continuity of the metrological 
traceability chain from the international level up to the nuclear medicine units. 
General Metrology uses the basic terms which are defined according to the International 
vocabulary of metrology – Basic and general concepts and associated terms (VIM), JCGM 200: 
2008: 
Primary reference measurement procedure, Primary reference procedure = Reference 
measurement procedure used to obtain a measurement result without relation to a measurement 
standard for a quantity of the same kind. 
Calibration = Operation that, under specified conditions, in a first step, establishes a relation 
between the quantity values with measurement uncertainties provided by measurement standards 
and corresponding indications with associated measurement uncertainties and, in a second step, uses 
this information to establish a relation for obtaining a measurement result from an indication. 
Measurement uncertainty = Non-negative parameter characterizing the dispersion of the quantity 
values being attributed to a measurand, based on the information used. 
Metrological traceability = Property of a measurement result whereby the result can be related to a 
reference through a documented unbroken chain of calibrations, each contributing to the 
measurement uncertainty. 
3.1 Activity measurement  
The national metrology laboratories dispose of two modalities to assure traceability in 
activity measurement. In many cases, they are Secondary Standard Laboratories (SSL), 
transferring the activity unit, Becquerel, from the well know and internationally recognized 
primary standard laboratories, like NIST (USA), LNHB (France), NPL (UK), PTB (Germany), 
etc. Alternatively, a national primary standard laboratory, recognized at the international 
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level, by demonstrating the equivalence of its standards to the International System (SI), can 
solve entirely this task. 
Figure 1 presents the equivalence and traceability chain to be established in activity 
measurement, from the International System (SI), assured by the International Bureau of 
Weights and Measures (Bureau International des Poids et Mesures-BIPM) through primary 
standard laboratories which disseminate the standards to the SSLs and end users, in our 
case the nuclear medicine units. In order to accomplish its duties, one primary laboratory 
has to solve the following tasks: it must set up the installations for absolute standardization 
of radionuclides, demonstrate its international equivalence and assure traceability to the 
lower levels. 
 
 
Fig. 1. Dissemination pathways for SI values of activity (From Woods & Sahagia. 2008). 
3.1.1 Methods and installations for primary (absolute) standardization 
The distinction between the radionuclide metrology and other metrology branches consists 
of the necessity to elaborate specific standardization methods almost for each radionuclide, 
due to the variability of decay schemes, and in the impossibility to construct an immuable 
standard, due to the radioactive dizintegration.  
In radionuclide metrology, an absolute standardization is done by the following procedure: 
one detects the radiations emitted by a radioactive source and the method for establishing 
an adequate relation between the counting rate and the activity of the source is elaborated. 
A general relation is expressed as: 
 0ε ε= =radN s A s N   (1) 
Nrad is the counting rate, s-1 (impulses per second) for the detected radiation; ε is the 
detection efficiency of the system; s, denoted also as (I, p) is the intensity of detected 
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radiations and A, or (N0) is the activity of the source, Becquerel (Bq). Every standardization 
operation aims to determine as precisely as possible the quantity ε, or to find a method to 
eliminate it from relation (1) 
Two basic methods are used, NCRP58 (1978). Methods based on the detection in a well-
defined geometry (defined solid angle), the most used being the 4πsr geometry, applicable 
for radionuclides emitting a single type of radiations, and coincidence methods used for 
those emitting coincident radiations. 
3.1.1.1 Methods based on determined geometry 
Solid angle method is based on the precise calculation of the solid angle, of the absorption 
in air and in detector window, and of the radiations scattering correction. The method is 
used for the standarization of the alpha sources, in vacuum chambers, provided with Si 
barrier surface detectors; in other cases, for example beta radiations, it is not satisfactory 
precise. 
Methods based on 4πsr geometry use a detection system assuring the quasi total detection 
of the radiations emitted by the source, which are used for measurement, what means that 
the following condition is fulfilled:  
 1ε ≈   (2) 
The method of the 4π proportional counter, known as the method 4πPC, is the most known. 
It is applicable to solid sources, or to radioactive solutions gravimetrically dropped on very 
thin solid supports, from pure beta emitters with high maximum energy, generally > 150 
keV. The remaining corrections to be applied are due to: beta rays absorption in source mass 
(selfabsorption) and in its support. The method is frequently used for the standardization of 
the radioactive gases and is known as „gas fillig counter” (Stanga et al.2002). The corrections 
are due to the wall nondetection, mainly the extremity of counters. Another applied method 
is the sum peak counting, based on the use of a large NaI(Tl) well type crystal, with a thin 
window (Nedjadi et al.2007). It is used for radionuclides emitting gamma radiations with 
high energies and intensities, as for example: 124Sb, 222Rn decay chain, etc. The corrections 
are done by using Monte Carlo programs. 
Liquid scintillator methods. The method is applicable to the radioactive solutions or gases, 
which are dissolved in a liquid scintillator. The detection geometry is 4πsr. The self-
absorption and source support absorption are eliminated but other processes occur: the 
quenching and non-detection of low energy radiations. It is applicable to pure alpha 
emitters, for which ε = 1, and high energy pure beta emitters.  
3.1.1.2 Coincidence methods 
The methods are generally applicable for the radionuclides decaying with the emission of 
mixed radiations, such as: ǂ – Ǆ; ǃ - Ǆ; x, eA – Ǆ. It is extended to the pure beta or electron 
capture radionuclides.  
Coincidence method and installation 4πPC-Ǆ. A classical coincidence installation contains: 
a proportional counter (PC), one or two NaI(Tl) detectors and electronic modules, allowing 
the individual recording of the impulses provided by the two detection channels, and the 
coincidences recorded by a coincidence selector. The principle of the method is the 
following: the relations between the counting rates on the three channels: proportional 
counter – NPC, gamma ray counting - NǄ, coincidence – Nc , the activity N0 and the 
corresponding detection efficiencies εPC and ε Ǆ , are:  
www.intechopen.com
 
Role of the Radionuclide Metrology in Nuclear Medicine 
 
149 
 0 0 0;    ;    γ γ γε ε ε ε= = =PC PC c PCN N N N N N   (3) 
Relations (3) are equivalent with:  
 0/γ =PC cN N N N   (4) 
Relation (4) shows that the efficiencies of the two detectors are eliminated and consequently 
the activity can be determined directly from the three counting rates. Relations (3) and (4) 
were written in very simplifying assumptions, which in reality can not be reached: the 
radiouclides have a simple decay scheme - an alpha or beta decay, followed by a gamma 
transition to the daughter ground level; the detectors are fully specialized; no perturbations 
due to the installation, such as background counting rate, dead times, resolution time of the 
coincidence circuit modifies the counting rates. The coincidence relations are more complex, 
and were written by (Gandy.1961) and (Baerg.1973). For decay scheme corrections the 
coincidence method is applied associated with an efficiency extrapolation variant, and for the 
instrumental corrections various formulae were deduced by (Grigorescu.1973) and 
(Smith.1978). Many specific methods were elaborated in the primary activity standard 
laboratories, among them being the Radionuclide Metrology Laboratory from the Horia 
Hulubei National Institute for Research & Development in Physics and Nuclear Engineering 
(IFIN-HH, RML) Bucharest, the Romanian owner of the primary activity standard. A 
coincidence installation was set up in the sixties and was continuously updated in this 
laboratory. The variant of the efficiency extrapolation, allowing to accomplish the decay 
scheme corrections, was developed and applied for many types of radionuclides. The 
classical extrapolation coincidence method was applied for the beta-gamma medical 
radionuclide 131I, for which the whole traceability chain was established (Sahagia et al.2008a). 
The therapy radionuclides 153Sm, 177Lu and 186,188Re, strong beta - weak gamma-ray emitters, 
have a “triangular” decay scheme and were standardized by a special extrapolation 
procedure (Sahagia et al.2005a,2005b,2002). For the radionuclide 99mTc, decaying by isomer 
transition in competition with internal conversion, a new type of coincidence scheme was 
applied, based on the coincidence between 119.5-138 keV conversion electrons and Tc x-rays 
(Sahagia.2006). Radionuclide 125I is an electron capture gamma emitter; it was standardized 
by the x - x, Ǆ coincidence method (Sahagia et al.2008b). The positron emitters, used for PET, 
PET/CT systems, like 68(Ge + Ga) generator, or other radionuclides decaying by electron 
capture in competition with positron emission, were standardized by the positron-
annihilation-ray coincidence, or combinations of radiations (Grigorescu et al.2004; Grigorescu 
et al.1996). In the present time, in many laboratories, the classical, analog, coincidence set up 
is replaced by the Digital Coincidence Counting (DCC) (Buckman et al.1998). At the same 
time, instead of the PC, a liquid scintillation counter (LSC), associated with a NaI(Tl) detector 
is used for coincidence measurement (Chylinski & Radoszewski.1996) 
Efficiency tracer method is an extension of the coincidence method applied for the 
standardization of pure beta decaying radionuclides. The solution to be standardized is 
mixed with a standard solution from a beta-gamma emitting radionuclide, preferable with a 
simple decay scheme, with a beta spectrum close to that of the radionuclide to standardize 
and chemically compatible with it. For the two radionuclide’s mixture, relation (3) becomes:  
 1 01 2 02 01 01 ;    ;    γ γ γε ε ε ε ε= + = =PC PC PC c PCN N N N N N N   (5) 
Index 1 refers to the tracer and 2 to the pure beta emitter. By an extrapolation procedure, a 
relation is established between the two εPC1 and εPC2 efficiencies, allowind the calculation of 
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activity N02 of the pure beta radionuclide.The method is applied for therapeutic pure beta 
radionuclides, like 89Sr, or other important radionuclides as 137Cs (Razdolescu et al.2002a, 
Sahagia.1981) 32P, 90Y.  
3.1.1.3 Advanced methods based on the liquid scintillation counting  
The method consists of mixing the radioactive solution with a liquid scintillator (LS). The 
energy of the radiations is transferred to the LS; it emits light photons, which produce 
photoelectrons, multiplied in a photomultiplier (PMT). Electron impulses are collected at the 
PMT anode. The detection efficiency is superior to that of proportional counters, but it 
depends strongly on the radiations energy. A calculation model, known as the „Free 
parameter principle” was developed, leaving from the idea that the sum of fenomena: 
luminous photons emission in LS, their arrival at PMT photocathode and emission of a 
photoelectron as result of interaction, is described by a Poisson distribution law. Another 
influence of LS is the quenching; it can be due to its chemistry, but the most important is the 
ionization quenching, Q(E), which is described by an empirical relation, written by 
(Birks.1964). Taking into account all these fenomena, a relation connecting the detection 
efficiency, ε, equal to the probability of producing a photoelectron, P(λ,E), with the counter 
parameters and ionizing radiation energy, E was deduced. (Broda et al.2007; 
Pochwalski&Radoszewski.1979):  
 
( )
( , ) 1
EQ E
RP E e λε λ −= = −   (6) 
λ is called the free parameter and R is the number of photomultipliers in the system. In 
relation (6) it is important to adjust the free parameter such as to reflect the measurement 
conditions. On this purpose, two main models were developed. 
CIEMAT/NIST method consists of the use of a LS counter provided with two PMTs in 
coincidence, in order to diminish the influence of background; commercial counters can be 
used. The adjustment of the free parameter is achieved by using an efficiency tracer, consisting 
of a tritium standard solution. The model contains several steps: a relation is established 
between the tritium detection efficiency and a quantity equivalent of the free parameter, 
known as quenching indicator parameter (QIP) (Grau Malonda.1999), measured by using the 
Compon radiation of an external source; a theoretical relation is calculated between the 
efficiency of tritium and that of the nuclide to standardize, for different QIP values, based on 
the beta spectra characteristics. Using a determined QIP value, one calculates the nuclide 
efficiency from the theoretical efficiency relation, corresponding to that QIP. 
Triple to double coincidence ratio (TDCR) method makes use of a special counter, 
provided with three PMTs, connected in double and triple coincidences. Leaving from the 
general equation (6), the efficiencies, equal to the probabilities of registration for the logical 
sum of double, εd , and respectively triple, εt , coincidences were written by (Broda et al.2007; 
Pochwalski&Radoszewski.1979):  
 
2 3( ) ( )
3 3
3( )
3
( ) 3 1 2 1
( ) 1
EQ E EQ E
d
EQ E
t
d E e e
t E e
λ λ
λ
ε
ε
− −
−
⎛ ⎞ ⎛ ⎞⎜ ⎟ ⎜ ⎟= = − − −⎜ ⎟ ⎜ ⎟⎝ ⎠ ⎝ ⎠
⎛ ⎞⎜ ⎟= = −⎜ ⎟⎝ ⎠
  (7) 
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These relations are calculated theoretically, from the radionuclide spectrum, by itteration for 
a big number of values of the free parameter ǌ, by using computer programs, like SPEBETA; 
TDRCB-1, 2, 7; DETECSZ, etc., elaborated at LNHB-France and RC Poland. On the other 
hand, an experimental ratio between the counting rates of the two types of coincidences, 
equal to the efficiencies’ ratio, is determined. They depend on the activity N0 and 
efficiencies, as: 
 0 0;D d T tR N R Nε ε= =   (8) 
The theoretical ratio of efficiencies, corresponding to the adjusted free parameter is the 
optimum, when: 
 d D
t T
R
R
ε
ε =  (9) 
In this manner, the efficiencies are determined, and the activity N0 is calculated from 
relations (8) 
A TDCR system was set up in IFIN-HH,RML, with the assistance of Dr. Philippe Cassette 
from LNHB. It was used for the standardization of radionuclides as 3H, 89Sr, 63Ni and was 
validated by international comparisons (Razdolescu et al.2004; 2006). Recently, a new 
counter was set up in RML, replacing the three PMTs with 6 channel photomultipliers 
(CPM) and designing a new optical chamber (Ivan et al.2010). It has the advantage of being 
compact and portable. 
3.2 Validation of the primary installations and methods; international equivalence 
3.2.1 The International System  
The International Committee for Weights and Measures (CIPM) coordinates the metrology 
branches through the Consultative Committees, as the Comité Consultatif des 
Rayonnements Ionisants – CCRI. CCRI is divided in three sections. The Section II, CCRI(II) - 
Measurement of Radionuclides, coordinates the Radionuclide Metrology. The Bureau 
International des Poids et Mesures-BIPM, Sèvres, http://www.bipm.org France, has the 
custody of the international standards. The equivalence of the primary standards is assured 
at this level by absolute methods of standardization. At the regional level, the Regional 
Metrology Organizations (MRO) are operational. In Europe there exist: EURAMET - 
European Association of National Metrology Institutes and COOMET - Euro-Asian 
Cooperation of National Metrology Institutes. The connection between BIPM and MROs is 
assured by the Joint Committee of the Regional Metrology Organizations and the BIPM - 
JCRB. At this level one assures the traceability also by using secondary (relative) 
standardization methods. The CIPM-MRA, Mutual Recognition Arrangement (1999), 
defines the recognition of the calibration and measurement certificates issued by the 
National Metrology Institutes. For example, Romania is part of CIPM-MRA. The document 
contains four annexes: Annex A - List of signatories; the Romanian signatory is the 
Romanian Bureau of Legal Metrology - National Institute of Metrology (BRML-INM); 
Annex B - Key Comparison Data Base (KCDB) per Institute; Annex C- Calibration and 
Measurement Capabilities (CMC); Annex D - Key Comparison Data Base. The condition for 
the applicability of CIPM-MRA by the signatory countries is the demonstration of the 
equivalence of the primary standards, or of the traceability for the others, such as presented  
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in figure 1. The equivalence is demonstrated only by the participation at international 
comparisons. IFIN-HH, RML, has participated at international comparisons since 1962. The 
Key Comparison Data Base (KCDB) Annex B of the CIPM – MRA, can be found at the address: 
http://kcdb.bipm.org/AppendixB/KCDB_ApB_search.asp. The participants in CIPM-MRA 
are the National Institutes of Metrology (NMIs), but for specialized metrology branches as 
the ionizing radiations, the participants can be the Designated Institutes. In Romania, 
according to the protocol concluded between BRML-INM and IFIN-HH it is established that 
IFIN-HH is designed as the owner of the primary activity (Becquerel) and derived quantities 
standard, with national and international responsibilities in the field: 
- Designed Institute as responsible for participation in the CIPM-MRA, included in Annex 
A of the CIPM-MRA, List of signatories. 
- Associated Institute to EURAMET, responsible for the Technical Committee of Ionizing 
Radiations, TC-IR 
Due to its scientific authority, IFIN-HH became also: Member of the International 
Committee for Radionuclide Metrology (ICRM) in 1980 and Member of the Consultative 
Committee Section II, CCRI(II), in 2004 
3.2.2 Validation of methods and establishment of equivalence by key comparisons  
Definition of the Key Comparisons, according to VIM: Selected comparisons taken formally 
into account for the establishment of equivalence. CCRI(II) may approve also supplementary 
comparisons, initiated by other organizations, to be used for establishment of equivalence: 
EURAMET, COOMET, IAEA, JRC-IRMM, etc. Relative methods may be used at this level, in 
order to extend the applicability of the CIPM-MRA, Annex C.  
The Comparisons are of the categories:  
- Comparisons type « CCRI(II)-K2. Radionuclide (Ex. Am-241)”. They are organized at 
worldwide scale. A single batch of radioactive solution is used for the preparation of all 
the samples which are sent to the participants, who measure and send to the BIPM the 
filled-in Reporting Form, containing the results. The reports are evaluated at BIPM and 
the Draft reports are drawn up. The Draft B is submitted to the approval of the CCRI(II) 
and published. For example, IFIN-HH, RML is registered with such comparisons in the 
KCDB with the radionuclides: 241Am, 109Cd, 139Ce, 134Cs, 137Cs, 152Eu, 55Fe, 3H, 125I (2), 
192Ir, 177Lu, 54Mn, 32P, 75Se, 89Sr, 204Tl, 65Zn.  
- Comparisons: “BIPM.RI (II)-K1.Radionuclide”. BIPM disposes of two reentrant (well type) 
ionization chambers, CENTRONIC IG11/20A, as the basis for creation of the 
International Reference System - SIR, for gamma-ray emitters (Ratel. 2007). The key 
comparison is carried out by the individual preparation and certification of an ampoule 
with standard solution by the participant laboratory, which is then sent to the BIPM 
with the Comparison filled-in Form. It is re measured at BIPM and the two results are 
compared. IFIN-HH, RML is registered with the radionuclides: 110mAg; 133Ba; 60Co (1983 
and 2007); 134Cs; 131I; 57Co; 137Cs  
- Supplementary Comparisons 
Type: “EURAMET.RI(II)-S5.Radionuclide”. These comparisons are deployed as Decay Data 
Evaluation Projects-DDEP. The first step of comparisons is similar to the CCRI(II)-K2. The 
second step consists of the measurement of the emission intensities for x and gamma-rays. 
IFIN-HH, RML is registered with: 169Yb; 65Zn; 124Sb. 
“IAEA-CCRI(II). Matrix content. Radionuclides”. These comparisons are organized within the 
frame of the International Atomic Energy Agency (IAEA) - Coordinated Research Projects 
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(CRPs) and are approved by the CCRI(II); they refer to special types of samples and relative 
methods are accepted. IFIN-HH, RML is registered as “CCRI(II)-S6.Radionuclide”, for the 
radionuclides 57Co and 131I, of interest in nuclear medicine.  
Establishment of the SI Activity Unit (Becquerel) by key comparisons. 
The Activity Unit is established individually for each radionuclide, after the evaluation of the key 
comparison result, which is expressed as the Key Comparison Reference Value – KCRV. 
Four methods are used to calculate the KCRV (Ratel.2007): arithmetic and weighted mean, 
median and weighted median. The most adequate variant is selected; in most cases, the 
arithmetic mean is preferred. The outliers are established after applying the exclusion 
criteria. The KCRV and its uncertainty are approved by the CCRI(II) and may be modified 
in time, after accumulating new results for the respective radionuclide. The “outliers” are 
not eliminated from KCDB, but their difference from KCRV must be taken into account 
when reporting the calibration uncertainties.  
When both the SIR-BIPM.RI(II)-K1.Radionuclide and the CCRI(II)-K2. Radionuclide 
comparison results are registered for the gamma-ray emitters, a link is established between 
the two types of comparisons, through the measurement in the BIPM ionization chamber of 
the ampoules sent for the K2 comparison.  
Equivalence. An equivalence matrix is calculated. Two main quantities are reported and 
compared: Difference between the individual result and KCRV, (Di) and its uncertainty (Ui), 
for a coverage interval k =2. The ratio of these quantities is the measure of degree of 
equivalence. The CCRI(II) approved “Draft B” is published in the KCDB and in Metrologia, 
Technical Supplement issues. IFIN-HH, RML, is registered in KCDB with 28 radionuclides.  
Equivalence validity. A validity interval was adopted by consensus. Consequently, in order to 
maintain the equivalence for some radionuclides, IFIN-HH repeated the comparison. It 
participated in 1983 and in 2007 at the SIR-BIPM.RI(II)-K1.Co-60 comparisons. As for 134Cs, 
the participations were: CCRI(II)-K2 in 1978 and SIR-BIPM.RI(II)-K1 in 2006 and for 137Cs, 
the participations were: CCRI(II)-K2 in 1982 and SIR-BIPM.RI(II)-K1 in 2009. 
Example: Analysis of the IFIN-HH, RML result at the medical 131I key comparison SIR-
BIPM.RI(II)-K.1.I-131, 2007 (Ratel et al.2008). KCRV = (40400 ±40) MBq; IFIN-HH value = 
(40371 ± 139) MBq; Di =0.07%; Ui=0.65% . Consequently, the IFIN-HH, RML’s result was 
taken into account in the calculation of the KCRV. 
SI Activity Unit (Becquerel) for other radionuclides. 
A matrix of radionuclides, codified by colors, according to the standardization difficulty by 
method, was established by the CIPM-CCRI(II) Key Comparison Working Group (KCWG), 
within the document Grouping Criteria Radionuclides for Supporting CMCs (Karam.2007). 
It can be used as follows. A red coded radionuclide measured by LSC, such as 3H, supports 
89Sr, 90Y, LSC measured, and green color coded. 
3.3 Implementation and recognition of the Quality Management System – Approval of 
CMC files 
An international agreement for the practical use of the results obtained by the National 
Metrology Institutes (NMI) in assurance of the traceability chain and recognition of the 
measurements and certificates was concluded through the document: “Joint statement by the 
CIPM and ILAC on the roles and responsibilities of national metrology institutes and national 
recognized accreditation bodies”. At the level of EURAMET, the implementation of the Quality 
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Management System (QMS) is monitored by the EURAMET, Technical Committee – 
Quality, TC-Q.  
At the level of CIPM - MRA, the statement is practically applied by the use of the Annex C 
of the CIPM-MRA, Calibration and Measurement Capability files – CMCs. The approval and 
publication of CMCs for a NMI is the result of two types of evaluation components for the 
international recognition: (i) Approval of the international equivalence for primary and of 
the traceability for secondary standards; (ii) Implementation of the QMS and recognition by 
the MRO’s, TC-Q. 
i. Approval of equivalence and traceability. The NMI, member of one MRO, draws up the 
primary or secondary CMC files. The statement is compared with the KCDB for 
primary, or in our case EURAMET for secondary standards. After the inter MROs’ peer 
review process, they are submitted for the approval of the JCRB. 
ii. Implementation and approval of the QMS. The EN/ISO/IEC 17025:2005, referential 
“General requirements for the competence of testing and calibration laboratories” is applied. A 
complete documentation and its implementation are presented at the annual meetings 
of the EURAMET, TC-Q. The technical experts monitor the documents and after the 
first approval, the QMS is annually reconfirmed. This is a prerequisite condition to 
maintain the CMCs in the published in Annex C of MRA. Example, IFIN-HH, RML 
situation. 34 CMC files, Radioactivity standards, passed the peer review process; the 
QMS was approved in 2007 and annually reviewed. All CMCs were approved by the 
JCRB in April 2008 and published in CIPM-MRA, Annex C. http://kcdb.bipm.org/ 
AppendixC/default.asp  
4. Setting up of the activity secondary standard systems 
Realisation of the activity secondary standards. 
Such as presented in figure 1 and as pointed in the references TRS 454 (2006) and 
(Zimmerman & Judge. 2007), the practical realization of the metrological traceability chain is 
possible by using the activity secondary standards. They are transfer instruments of the 
activity unit from the primary to the lower order, working standards, for the end users, 
through standard (reference) products or calibration services. They consist of installations 
for the secondary (relative) standardization; their calibration is done with sources and 
solutions absolutely standardized with the primary standards. In the case of the primary 
laboratories they use their own primary standards. In the case of the secondary standard 
laboratories (SSL), the standards leave from another primary laboratory, the traceability 
route being declared. The practical work at IFIN-HH, RML was described in (Sahagia & 
Woods.2008). 
4.1 Secondary standards for high activity radiopharmaceutical solutions 
The secondary standard for high activity solutions is a reentrant (well type) ionization 
chamber, filled with an inert gas as nitrogen or argon, at high pressure, of a special 
construction, largely described by H. Schrader in Monographie BIPM-4 (1997), or a 
commercial radionuclide calibrator. It is calibrated with standard solutions absolutely 
standardized, from the radionuclides of interest. The ionization current, registered by the 
associated electrometric circuit, is due to the radiations entering in the sensitive volume of 
the chamber and ionizing the filling gas. This chamber is mainly used for the measurement 
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of activity for gamma-ray, but also for strong beta-ray emitters, when the ionization current is 
produced by the bremsstrahlung radiations. Usually, the calibration factor is expressed in 
terms of absolute or relative efficiency, or in ionization current per activity unit, pA MBq-1. The 
calibration must be performed for several geometries of the recipients containing radioactive 
solution, or gelatin capsules in the case of iodine radioisotopes, as the calibration factor 
depends on the geometrical dimensions. For example, the IFIN-HH, RML well type ionization 
chamber is of the type CENTRONIC IG12/20A, filled with argon at a pressure of 2MPa 
(20Atm); its construction was first described in (Grigorescu et al. 2003). Recently, the old 
electrometric system was replaced with an electrometer Keithley E6517A. The validation of the 
calibration factors was done by several comparisons: (i) with the measurements performed at 
PTB-Braunschweig-Germany with PTB standard solutions; (ii) with the IFIN-HH, RML results 
obtained in international comparisons; (iii) respectively with the value of the KCRV (Sahagia et 
al. 2010). The calibration factors are determined for the radionuclides: 241Am, 57Co, 99mTc, 186Re, 
188Re, 153Sm, 177Lu, 75Se, 169Yb, 131I, 133Ba, 51Cr, 192Ir, 134Cs, 137Cs, 54Mn, 65Zn, 60Co, 152Eu and for 
three geometries: (i) Solid sources; (ii) 131I gelatin capsules; (iii) Solutions of volumes: 2 mL 
(PTB), 3.6 mL (SIR-BIPM), 5 mL (P6 used for radiopharmaceuticals). From the above list one 
may notice that the calibration is assured for the majority of medical radionuclides. The 
determined calibration factors allow the measurement and certification of the 
radiopharmaceutical solutions or capsules to be used for: (a) the calibration of the radionuclide 
calibrators, including those belonging to the radiopharmaceutical unit from IFIN-HH, (b) to be 
distributed to the interested laboratories, or (c) to be used for organization of national 
comparisons. The chamber operation is in compliance with the QMS rules, established in 
agreement with the requirements of the EN ISO/IEC 17025:2005 and TRS 454 document. The 
calibration uncertainty is in all cased less than 2.0%.  
4.2 High resolution spectrometric system 
In the field of nuclear medicine, spectrometric systems are used for the measurement of the 
radionuclide impurity level in radiopharmaceuticals (RPMs); in order to perform an 
adequate check of the requirements imposed to the RPMs, the system must have a high 
resolution, to allow the identification of the main radionuclide and impurities, and to be 
sensitive enough (to have a low background) in order to detect impurities content of the 
order of <0.1%, such as it is required for 99Mo content in 99mTc.  
IFIN-HH, RML disposes of a system containing a high resolution HPGe detector: relative 
efficiency 29%; energy interval 35 keV – 3 MeV; resolution: 0.85 keV (122 keV) and 1.74 keV 
(1.332 MeV) and a computer driven, software GAMMA VISION, V 6.01 spectrometric 
analyser. The specialized program GESPECOR (Sima & Arnold. 2002), for geometry, matrix 
and coincidence summation corrections is implemented. An efficient shield, consisting from: 
10 cm old lead; 1 mm tin; 2 mm electrolytic cooper, assures a maximum integral background 
rate on the whole energy interval of 1.4 s-1. The system is calibrated in terms of energy and 
efficiency with standard sources, in various geometries from point sources up to volume 
recipients, prepared from standard solution absolutely standardized, by the coincidence 
method. Various distances, from zero, up to 44.3 cm from the detector surface are used in 
measurements, depending on the activity interval. The calibration of the system was also 
validated by the participation at international NPL-UK or IAEA exercises for the measurement 
of various volume samples, containing mixtures of radionuclides (Luca et al. 2010). The system 
is taken as reference for the dedicated HPGe spectrometer used in the radiopharmacy unit. 
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Another use of the IFIN-HH, RML’s spectrometric system is the precise determination of the 
emission intensity of gamma-rays for radionuclides of medical use. These parameters are of 
maximum importance for activity standardization by primary methods, as in most of 
measurements they are basic parameters in activity calculation. On the other hand, the 
efficiency and safety of the medical procedure depends directly on their precise knowledge. 
The precise value of half life is directly used in nuclear medicine units for the calculation of 
activity at the moment of administration. The calculation of patients’ doses is based on the 
values of: activity, half life, radiations  - types, energies and emission intensities. On the 
international scale, projects of the type: “EURAMET.RI(II)-S5.Radionuclide” are organized, 
for the experimental determination of emission intensities and evaluation projects 
coordinated by the Decay Data Evaluation Program (DDEP) are deployed. IFIN-HH, RML 
participates in both types of programs. For example, recently the laboratory participated at 
the exercise, organized for the new PET radionuclide 64Cu, EURAMET project 1085 (Bé et al. 
2011). RML standardized absolutely solutions from 64Cu and 68Ga by the coincidence 
method (Sahagia et al. 2011). Point solid sources from standard solution were prepared 
gravimetrically, and were used for the determination of their decay parameters: gamma-
rays emission intensities with the calibrated HPGe spectrometric system and half life by the 
use of the CENTRONIC IG12/20A ionization chamber (Luca et al.2011). 
5. The Radionuclide Metrology Laboratory support to the nuclear medicine 
A primary/secondary standard laboratory is the entity which can assure the continuity of 
the metrological traceability in the measurement and characterization of 
radiopharmaceuticals in radiopharmacy units, national control authorities and hospitals 
from the top level, SI, up to the end user, the patient, by the following standards delivery 
and calibration operations (Zimmerman et al. 2007): 
- Radioactive standards to be used in the interested entities;  
- Calibration or Metrological Check of the Radionuclide Calibrators;  
- Organization of national comparisons and proficiency tests.  
These activities need to be accomplished under the regime of national accreditation, as a 
Calibration and Testing Laboratory, according to the provisions of the standard EN 
ISO/IEC 17025:2005 “General requirements for the competence of testing and calibration 
laboratories”. For example IFIN-HH, RML obtained the accreditation for both types of 
activities, from the Romanian accreditation body, RENAR, member of the European 
Accreditation (EA), for the products and services for clients, after implementing a Quality 
Management System (QMS). The QMS consists of the documentation and practical 
realization of the documents’ provisions. The main documents, covering the Chapters 4 and 
5 of the EN ISO/IEC 17025:2005 standard, are: RML Manual-containing the basic statement 
of the QMS, an Organizational procedure and two sets of procedures: System (Management) 
procedures (MP) and Work procedures (WP) and instructions (WI). The accreditation was 
obtained in 2009, for a 4-year period; annual survey audits of RENAR representatives are 
done. In contrast with other calibration or testing laboratories, where the accreditation refers 
to some well-defined activities, in our quality of primary standard laboratory, we have first 
of all the responsibility for the quality of primary, absolute standardizations, on the top of 
traceability chain, not in direct connection with customers’ requirements. The first 
consequences are: (i) The traceability chain must be well defined and demonstrated in the 
laboratory. (ii) An internationally recognized expert must conduct the technical evaluation 
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of the laboratory. On the other hand, as a national provider of radioactive standards, the 
RML must meet quality requirements in their production.  
(i) Definition of Activities and Establishment of Traceability Chain. Clear distinction of the two 
types of activities in relation with the RENAR accreditation was defined: Calibration 
activities and Testing activities. (a) The calibration branch required a sharp definition of the 
traceability chain and activities deployed in regime of quality management. The declared 
activities under accreditation are: (I) Attestation of the installations for the absolute (direct) 
standardization, mainly used for international comparisons, in order to prove the 
international equivalence of the Romanian standards, and for the preparation of standard 
sources and solutions used for the calibration of the secondary equipment. (II) Calibration 
and metrological check of the secondary installations for the relative (indirect) 
standardization. (III) Standardization of the radioactive standard sources and solutions. (IV) 
Preparation and relative or absolute standardization of radioactive sources and solutions, 
under the quality management system. The traceability chain continues outside the 
laboratory, in connection with the users, and implies: (V) The delivery of radioactive 
sources, with Calibration Certificates, under the quality management system. (VI) The 
calibration and metrological check of activity measurement installations. (VII) The 
organization of inter laboratory comparisons (ILCs) and proficiency tests (PTs) for the 
testing and calibration laboratories. (b) The testing branch of accredited activities refers at 
the Analysis of very low activity samples by the gamma-ray spectrometry. Another special 
aspect in the application of the requirements of the 17025:2005 Standard in our case is the 
responsibility of the National Nuclear Authority (CNCAN) regarding the radioprotection of 
the workers, public and patients. In this respect IFIN-HH, RML was CNCAN designed also 
as a notified calibration and testing laboratory for the nuclear field.  
5.1 Radioactive standards for nuclear medicine  
The calibration and metrological check of the equipment for measurement of the 
radioactivity imposed the development of technics for the preparation of a large variety of 
standard sources and solutions, to be used in-house, or delivered to the external customers 
which are performing radioactivity measurement. A general WP, coded AC-PL-LMR-10, 
describes the common operations and detailed WIs present the specific operations. 
Radioactive Solutions. A large variety of radioactive solutions, physico-chemically stable, adequate 
as radioactivity standards, are prepared (Grigorescu et al.1975). Some of them, even for external 
users’ delivery, are standardized absolutely, or alternatively, by the use of the calibrated 
ionization chamber. They are certified in terms of radioactive concentration, Bq g-1, and in total 
activity, Bq, per recipient, flame or mechanically sealed in glass ampoules or P6 vials. 
Point and Large Area Alpha and Beta Sources. These sources are of immediate interest, both for 
calibration of contamination monitors (contaminometers), as well as for the effective 
measurement of the so called “Gross Alpha” and “Gross Beta” radioactive content of 
environmental, industrial and food chain samples. Their preparation and measurement of 
the particle emission rate in a 2πsr geometry are described in (Sahagia et al. 1996a). 
5.2 Calibration and metrological check of measurement equipment  
The main requirements regarding the characteristics of the equipment for the measurement 
of activity and of the physico-chemical parameters were described in section 2. In order to 
satisfy them, a radionuclide metrology laboratory is asked to perform calibrations or other 
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metrology checks over it. The radionuclide calibrators are the most used devices for the 
measurement of activity in radiopharmacy, control units and hospitals (Razdolescu et 
al.2002b). In some cases the National Metrology legislation imposes their metrological 
control, according to legal metrology norms, and in others it is required their calibration at 
defined time intervals, by a metrology laboratory, accredited for calibration. In our case, the 
legal metrological control was mandatory until 2009. Starting with 2010, the calibration-
recalibration was preferred. In this respect, IFIN-HH, RML obtained the RENAR 
accreditation for these operations within its QMS. The WP codified as AC-PL-LMR-11 is 
applied. As a general remark from our calibration experience is that the Romanian hospitals 
staff increased in time its awareness regarding the quality of activity measurement and 
more and more nuclear medicine units benefit from our laboratory’s services of calibration, 
at present time regarding the radionuclides: 99mTc and 131I. The deviations of the calibration 
factors from the reference values are generally within ±5%. The IFIN-HH radiopharmacy is 
under the permanent metrological survey of the RML. As this unit has under study new 
radiopharmaceuticals, the laboratory was asked to assess calibration factors to the 
radionuclide calibrators for the new radiouclides: 186Re, 188Re, 153Sm, 177Lu.  
The second important action is the calibration of the HPGe spectrometric system used in the 
radiopharmacy for the control of radionuclidic impurities. It is calibrated and regularly 
recalibrated in energy and efficiency by the representatives of RML, using standard 
solutions prepared in RML, under accreditation regime, and the calibration procedure WP 
code AC-PL-LMR-0100 is applied. 
Other equipment, belonging the radiopharmacy unit, are the radiochromatographs used in 
the control of the radiochemical purity; for their calibration and linearity check, a set of solid 
point standard gamma-ray emitting sources are used; for the case of 131I control, two 133Ba 
standard sources are measured. The action is also under accreditation regime and the WP 
code AC-PL-LMR-12 is applied.  
Each nuclear medicine unit, operating with open radioactive sources, is provided with 
contaminometers for the control of radioactive contamination of surfaces, devices, clothes, 
operator hands, etc., which can occur during the medical procedures. This equipment can be 
under the legal metrological control of the state as it is in Romania, or only is recalibrated at 
defined intervals. The Romanian secondary standard laboratories performing these checks 
use large area standard sources emitting beta radiations, in most cases 90(Sr+Y) sources. 
IFIN-HH, RML is the provider of these standard sources and also performs their calibration 
(Sahagia et al. 1996b). 
5.3 Organization of national comparisons and proficiency tests 
The most significant test, recognized as relevant in the evaluation of the capability of a 
laboratory performing measurements, is the participation in proficiency tests. For example, 
even when the calibration factors of the radionuclide calibrators are correct, the 
measurement in a hospital implies also the skill of the operating staff. Non experienced 
people are possible to choose wrong calibration factors’ values, to do wrong readings and 
activity calculation on the administration time. From our practical experience, one may 
conclude that the proportion of laboratories with unsatisfactory results in proficiency tests is 
higher than that of wrong calibrated equipment. This is the reason for which in some 
countries the participation in proficiency tests is mandatory, but in others like Romania, it is 
only voluntary. IFIN-HH, RML organized in the past several national comparisons mainly 
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for a scientific output, in order to understand which explanations for noncorresponding 
results are. The comparisons regarded the measurement of 131I (Sahagia et al.1996b) and the 
set 99mTc and 57Co, (Sahagia & Woods. 2008c). Within the frame of the above cited IAEA, 
CRP E2.10.05, a series of international actions were deployed, in order to harmonize the 
measurements in the participant countries, all over the world. The actions were organized in 
two steps. The first step was the participation of the national reference laboratories (primary 
or secondary) in two comparisons organized by the IAEA, recognized also as 
supplementary CCRI(II) –S6 comparisons, on 131I and 57Co (used a as mock solution for 
99mTc), intended to verify their calibration capability. The results were presented by the 
comparisons organizers in the papers (Zimmerman et al. 2008; Zimmerman & Palm. 2010). 
After the evaluation of the results, each national laboratory organized then two national 
comparisons, for the radionuclides 131I and 99mTc. IFIN-HH, RML organized the 
comparisons according to the prescriptions of the WP code AC-PL-LMR-07, written in 
accordance with the international documents: ISO Guide 43 „Proficiency testing by 
interlaboratory comparisons” Part 1: „Development and operation of proficiency testing schemes” 
and Part 2: „Selection and use of proficiency testing schemes by laboratory accreditation bodies” and 
following also the recommendations from the Protocols on the organization of national 
comparisons of radiopharmaceuticals, established within the frame of the IAEA CRP. 
E2.10.05.The analysis of the results was reported in the papers (Sahagia et al. 2009; Sahagia 
et al. 2010b). As conclusions from these tests are the proportions of hospitals measuring 
satisfactory the activities of the two radionuclides. In the case of 131I, from a total number of 
15 reported values, a number of 11 results are within the difference limit from reference value 
<5%, and 12 results within the limit <10%, a proportion of 80% from participating units, being 
in compliance with the Pharmacopoeia; for 99mTc, from 7 reported values, a number of 5 results 
are within < 5 % difference from the reference value, and 7 results within the limit < 10 %, a 
proportion of 100% from participating units. Regarding 131I comparisons, after finalizing the 
IAEA CRP. E2.10.05, an interesting paper, summarizing all 8 national laboratories 
comparisons’ organization and results was published recently (Olsovcova et al. 2010); a 
similar paper is in preparation, for presentation of the 99mTc national comparisons. 
6. Conclusions  
- Nuclear medicine benefits from a very wide range of radionuclides, to be used as 
radiopharmaceuticals for diagnosis and therapy procedures. 
- The radiopharmaceuticals are classified as high pharmaceutical risk products, and 
therefore they must be very carefully characterized in terms of the main parameters: 
metrological, physico-chemical, biological. 
- The precise measurement of activity is of crucial interest, as it determines directly the 
committed effective dose of the patient in diagnostic and organ/tissue absorbed dose in 
therapy. 
- Precise measurements of activity are also implied indirectly in the full characterization 
of the radiopharmaceuticals’ parameters. 
- The Radionuclide Metrology Laboratory can assure the metrological traceability chain 
for activity starting from the primary level, by demonstrating its international 
equivalence, or starting from the secondary one, the traceability route being necessary 
to be declared. 
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- The Radionuclide Metrology Laboratory can offer the necessary support to the nuclear 
medicine for the safe and efficient use of radiopharmaceuticals, by assuring the 
standards and the metrology services to the implied entities: radiopharmacy, control 
laboratories, equipment producers, nuclear medicine units. 
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